Literature DB >> 14615060

Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells.

Heng Qi1, Josée Grenier, Andréa Fournier, Claude Labrie.   

Abstract

The NEDD4L gene encodes a ubiquitin ligase that targets the epithelial sodium channel for degradation. A search for transcripts whose levels increase following androgen treatment of LNCaP human prostate cancer cells led to the isolation of three new NEDD4L transcripts designated NEDD4Lf, NEDD4Lg and NEDD4Lh. The three transcripts encode different forms of the NEDD4L protein, two of which contain an N-terminal C2 domain. These transcripts were detected at high levels in human prostate and mammary gland, and at lower levels in brain and skeletal muscle. We also found that the previously described NEDD4La and NEDD4Lc (KIAA0439) transcripts are also expressed in prostate and LNCaP cells. However, only NEDD4Lf, NEDD4Lg and NEDD4Lh were up-regulated by androgen in LNCaP cells. These data provide new information on the structure and expression profile of NEDD4L-derived transcripts and identify specific isoforms of the NEDD4L ubiquitin ligase as proteins with potentially important roles in androgen action and prostate physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615060     DOI: 10.1016/j.mce.2003.08.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

Review 1.  SMURF and NEDD4: sharp shooters monitor the gate keepers and ion traffic controllers of lead astray cell.

Authors:  Ammad Ahmad Farooqi; Makhdoom Saad Waseem; Asma M Riaz; Shahzad Bhatti
Journal:  J Membr Biol       Date:  2011-09-15       Impact factor: 1.843

Review 2.  NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins.

Authors:  Pranay Goel; Jantina A Manning; Sharad Kumar
Journal:  Gene       Date:  2014-11-26       Impact factor: 3.688

3.  Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient.

Authors:  Chengcheng Gao; Liqun Pang; Chengcheng Ren; Tianheng Ma
Journal:  Med Oncol       Date:  2011-09-11       Impact factor: 3.064

4.  Down-regulation of intestinal apical calcium entry channel TRPV6 by ubiquitin E3 ligase Nedd4-2.

Authors:  Wei Zhang; Tao Na; Guojin Wu; Haiyan Jing; Ji-Bin Peng
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

5.  NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathway.

Authors:  Rui Feng; Zhongxing Li; Guangcheng Ge; Chenghao Wang; Yuejun Jia; Jun Ouyang
Journal:  Clin Transl Oncol       Date:  2022-09-22       Impact factor: 3.340

6.  Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.

Authors:  Hua Li; Ahmed A Mohamed; Shashwat Sharad; Elizabeth Umeda; Yingjie Song; Denise Young; Gyorgy Petrovics; David G McLeod; Isabell A Sesterhenn; Taduru Sreenath; Albert Dobi; Shiv Srivastava
Journal:  Oncotarget       Date:  2015-06-20

7.  SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.

Authors:  Jia Liu; Lixin Wan; Pengda Liu; Hiroyuki Inuzuka; Jiankang Liu; Zhiwei Wang; Wenyi Wei
Journal:  Oncotarget       Date:  2014-02-28

8.  DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.

Authors:  Ran Zhao; Tiantian Cui; Chunhua Han; Xiaoli Zhang; Jinshan He; Amit Kumar Srivastava; Jianhua Yu; Altaf A Wani; Qi-En Wang
Journal:  Nucleic Acids Res       Date:  2015-06-29       Impact factor: 16.971

9.  Genetic variation of NEDD4L is associated with essential hypertension in female Kazakh general population: a case-control study.

Authors:  Nanfang Li; Hongmei Wang; Jin Yang; Ling Zhou; Jing Hong; Yanying Guo; Wenli Luo; Jianhang Chang
Journal:  BMC Med Genet       Date:  2009-12-09       Impact factor: 2.103

10.  The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes.

Authors:  Jingqi Fu; Dmitry Akhmedov; Rebecca Berdeaux
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.